Modern approach to the evaluation of the pharmacokinetics and pharmacodynamics of biosimilar recombinant human insulin and insulin analogues in I phase clinical study
The quality, pharmacokinetic and pharmacodynamic profiles, safety and immunogenicity must be compared to demonstrate the bio-similarities of recombinant human insulin and insulin analogues. To confirm these bio-similarities in clinical studies, it is necessary to adhere to a multi-phased approach, s...
Saved in:
Main Authors: | Irina A. Proskurina, Alexander Y. Mayorov, Dmitriy V. Gorachev, Natalya D. Bunyatyan |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/c78b0f616f6e43df9840cb2fd1e823af |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
by: Marina Vladimirovna Shestakova, et al.
Published: (2015) -
Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2012) -
Enzyme-Linked Immunosorbent Assay Method Application in the Study of Comparative Pharmacokinetics of Insulin Glargin Preparations
by: L. N. Shitov, et al.
Published: (2019) -
Assessment the equivalence of the bioanalogue insulin lizpro biphasic 25 (Geropharm-bio, Russia) and Humalog® Mix 25 (Lilly France, France) using the euglycemic hyperinsulinum clamp method on healthy volonters
by: Alexander Y. Mayorov, et al.
Published: (2018) -
Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
by: Tatiana Ivanovna Romantsova, et al.
Published: (2013)